Document Detail

The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
MedLine Citation:
PMID:  3011235     Owner:  NLM     Status:  MEDLINE    
A program to reduce the incidence of erythroblastosis fetalis was started in Nova Scotia in 1964. Up to the end of 1984, 120 fetuses received 247 intrauterine transfusions. The survival rate was 45.6% in the first 10 years of the program and 66.7% in the next 11 years. For fetuses at or over 26 weeks' gestation the figures were 51.5% and 73.7% respectively. Postpartum prevention was started in 1968, with administration of Rh immune globulin (RhIG) to Rh-negative unimmunized women within 72 hours after the birth of an Rh-positive infant. Antepartum prevention, started in 1979, consisted of administration of RhIG at 28 weeks' gestation to Rh-negative unimmunized women. The effectiveness of the prevention program was evaluated by enumerating the known cases of Rh(D) alloimmunization in the province from 1982 to 1984: 55 cases were identified, a rate of 1.5 per 1000 births instead of the expected rate of about 10 per 1000.
T F Baskett; M L Parsons; L J Peddle
Related Documents :
22096335 - Periodontitis: a risk for delivery of premature labor and low-birth-weight infants.
903855 - Effect of shear mixing on in vitro drug release of capsule formulations containing lubr...
6210865 - Death following puncture of the aorta during laparoscopic sterilization.
1816665 - Prevention of neonatal hypothermia in himalayan villages. role of the domiciliary caret...
16684905 - Evaluation of breastfeeding of very low birth weight infants: can we use the infant bre...
10323705 - Congenital nasal pyriform aperture stenosis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne     Volume:  134     ISSN:  0820-3946     ISO Abbreviation:  CMAJ     Publication Date:  1986 Jun 
Date Detail:
Created Date:  1986-06-30     Completed Date:  1986-06-30     Revised Date:  2010-09-09    
Medline Journal Info:
Nlm Unique ID:  9711805     Medline TA:  CMAJ     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  1259-61     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Transfusion, Intrauterine
Erythroblastosis, Fetal / mortality,  prevention & control,  therapy*
Immunization, Passive
Immunoglobulins / administration & dosage
Infant, Newborn
Nova Scotia
Rh Isoimmunization / prevention & control
Rh-Hr Blood-Group System
Rho(D) Immune Globulin
Reg. No./Substance:
0/Immunoglobulins; 0/Rh-Hr Blood-Group System; 0/Rho(D) Immune Globulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Surgical treatment of lung cancer: promise and problems of early diagnosis.
Next Document:  Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prog...